X-group (possible homology)

3861 Mitochondrial translocator protein (TSPO)

Ligands and drugs

106
Member domains
32
with ligand contacts (≤ 4 Å)
30.2% of members
31
with DrugDomain annotations
29.2% of members
13
with a DrugBank compound
12.3% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

3
Proteins with classified ligands
4
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Lipids and lipid-like molecules20.36.07×not tested
Organoheterocyclic compounds20.54.39×not tested
Organic oxygen compounds10.61.70×not tested
Homogeneous non-metal compounds10.61.57×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB02285PP9Protoporphyrin4
DB03831MPG[(Z)-octadec-9-enyl] (2R)-2,3-bis(oxidanyl)propanoate4
DB18267HEMFerroheme4
DB01178——1
DB01198——1
DB03279LMUDodecyl-Alpha-D-Maltoside1

Most frequently bound compounds

PDB ligandNameDomains in contact
OLC(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate21
MPG[(Z)-octadec-9-enyl] (2R)-2,3-bis(oxidanyl)propanoate6
HEMPROTOPORPHYRIN IX CONTAINING FE4
PKAN-[(2R)-butan-2-yl]-1-(2-chlorophenyl)-N-methylisoquinoline-3-carboxamide4
PP9PROTOPORPHYRIN IX4
P6L(2S)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(6E)-HEXADEC-6-ENOYLOXY]PROPYL (8E)-OCTADEC-8-ENOATE3
MH0Mesoheme2
OXYOXYGEN MOLECULE2
Z0P(2S)-1-(hexadecanoyloxy)-3-hydroxypropan-2-yl (11Z)-octadec-11-enoate2
IODIODIDE ION1
LMUDODECYL-ALPHA-D-MALTOSIDE1
MOEMETHOXY-ETHOXYL1
P4CO-ACETALDEHYDYL-HEXAETHYLENE GLYCOL1
YZY(2S)-2-(hexadecanoyloxy)-3-hydroxypropyl (9Z)-octadec-9-enoate1